
ICON plc | Clinical Research Organisation (CRO) for Drug …
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
CROI Conference
Attend or submit a registration, check your presentation information (including poster number), access CROI materials (eg, abstract book) for registrants. Access for registered attendees. To access the conference resources, use the same IAS–USA/CROI account login credentials that you used to register for CROI 2025.
120亿美元,ICON跃居全球CRO第二,开启远程CRO新赛点?-36氪
2月24日,总部位于都柏林的CRO企业 ICON宣布将以120亿美元的股票和现金收购美国CRO 企业PRA Health Sciences。 这一价格比PRA(23日)收盘溢价30%。 合并成功后,使ICON将跃升为仅次于IQVIA的全球第二大CRO企业。 根据财报,目前全球CRO领域,PRA排名第五,ICON排名第六。 IQVIA也是2016年由IMS...
ICON PLC - Wikipedia
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. [2] .
ICON | Global CRO | We've developed 18 of the world's top 20 …
We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations.
ICON plc | Clinical Research Organisation (CRO) for Drug …
ICON is a global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
服务 | ICON plc China
ICON可提供涵盖广泛的专业化服务,助力制药、生物科技和医疗器械公司更快地将新药和器械推向市场。 我们的服务涵盖产品开发的整个生命周期,既适用于小型本地试验,也适用于大型 …
120亿美元!ICON跃居全球CRO第二,开启远程CRO新赛点?
2021年3月1日 · 2月24日,总部位于都柏林的CRO企业 ICON宣布将以120亿美元的股票和现金收购美国CRO 企业PRA Health Sciences。 这一价格比PRA(23日)收盘溢价30%。 合并成功后,使ICON将跃升为仅次于IQVIA的全球第二大CRO企业。 根据财报,目前全球CRO领域,PRA排名第五,ICON排名第六。 IQVIA也是2016年由IMS Health和Quintiles进行的170亿美元以上巨额合并产生的。 ICON首席执行官Steve Cutler在周三的电话会议上表示:“多年来,我们一直在寻 …
ICON | Global CRO | We've developed 18 of the world's top 20 …
We are a global provider of outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations.
Global CRO | Acquisitions & History - ICON plc
ICON acquires KCR, a mid-size CRO, founded and headquartered in Poland, offering full service and functional service provision clinical trial services. ICON acquires HumanFirst, a cloud …